It has been shown that this calmodulin-inhibiting antipsychotic drug repressed AQP4 localization to the blood-spinal cord barrier, ablated AQP4-mediated cerebral edema, and led to accelerated functional recovery in rats [105]. The gene discussed is AQP4; the disease is edema.